{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:51:20Z","timestamp":1780372280159,"version":"3.54.1"},"reference-count":48,"publisher":"Termedia Sp. z.o.o.","issue":"4","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:p>Spondyloarthritis (SpA) is often complicated with subclinical gut inflammation. This study was aimed at searching for biomarkers discriminating SpA patients with and without intestinal symptoms. A\u00a0group of 29 SpA patients and 33 healthy volunteers (control) were included in the study. Based on clinical evaluation, the patient cohort was subdivided into two groups: 1) SpA accompanied by various intestinal symptoms suggesting gut inflammation (group 2, n = 14) and 2) without such complications (group 1, n = 15). Serum concentrations of interleukins (IL) (IL-10, IL-17A\/F, IL-22, IL-23), tumour necrosis factor (TNF), bone-homeostasis-related factors (osteoprotegerin \u2013 OPG and Dickkopf-1 \u2013 DKK-1), and the concentrations of selected gut inflammation-associated factors (intestinal fatty acid binding protein \u2013 iFABP, claudin 3 \u2013 CLDN3 and calprotectin) in samples of sera and\/or urine or stool, respectively, were measured by specific ELISA. Serum concentrations of tested factors were similar in SpA patients and control. Faecal calprotectin level was higher in patients but did not discriminate between group 1 and 2. Compared to group 1, group 2 was characterized by elevated erythrocyte sedimentation rate (ESR), higher serum CLDN3 and DKK-1 levels. In SpA patients, serum DKK-1 concentrations correlated with systemic inflammation markers (R = 0.6, p &lt; 0.01), while serum CLDN3 was found to be an independent risk factor (OR = 4.5, p = 0.021) for the occurrence of intestinal symptoms. We conclude that in SpA patients, up-regulated circulating levels of CLDN3 seem to be related to intestinal complication, while the quantity of circulating DKK-1 reflects the intensity of systemic inflammation.<\/jats:p>","DOI":"10.5114\/ceji.2019.92802","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T03:44:13Z","timestamp":1582688653000},"page":"414-422","source":"Crossref","is-referenced-by-count":3,"title":["Spondyloarthritis patients with and without intestinal symptoms \u2013 searching for discriminating biomarkers"],"prefix":"10.5114","volume":"44","author":[{"given":"Ewa","family":"Kontny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Dmowska-Chalaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2020,1,20]]},"reference":[{"key":"ref-1547445","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/rheumatology\/ket407","article-title":"Spondyloarthritis: from unifying concepts to improved treatment","volume":"59","author":"Paramarta JE","year":"2014","unstructured":"Paramarta JE, Baeten D (2014): Spondyloarthritis: from unifying concepts to improved treatment. Rheumatology (Oxford) 59: 1547-1559.","journal-title":"Rheumatology (Oxford)"},{"key":"ref-1547446","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/ar4228","article-title":"Microbes, the gut and ankylosing spondylitis","volume":"15","author":"Costello ME","year":"2013","unstructured":"Costello ME, Elewaut D, Kenna TJ, Brown MA (2013): Microbes, the gut and ankylosing spondylitis. Arthritis Res Ther 15: 214.","journal-title":"Arthritis Res Ther"},{"key":"ref-1547447","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/reum.2014.44704","article-title":"New aspects of spondyloarthritis pathogenesis. Part III\u2013arthritis, pathological bone remodeling","volume":"52","author":"Kontny E","year":"2014","unstructured":"Kontny E (2014): New aspects of spondyloarthritis pathogenesis. Part III\u2013arthritis, pathological bone remodeling. Reumatologia 52: 247-254.","journal-title":"Reumatologia"},{"key":"ref-1547448","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.berh.2006.03.010","article-title":"Ankylosing spondylitis and bowel disease","volume":"20","author":"Rudwaleit M","year":"2006","unstructured":"Rudwaleit M (2006): Ankylosing spondylitis and bowel disease. Best Pract Clin Rheumatol 20: 451-471.","journal-title":"Best Pract Clin Rheumatol"},{"key":"ref-1547449","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestation in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk C","year":"2015","unstructured":"Stolwijk C, van Tubergen A, Castillo-Ortiz JD, Boonen A (2015): Prevalence of extra-articular manifestation in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Rheum Dis 74: 65-73.","journal-title":"Ann Rheum Dis"},{"key":"ref-1547450","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model","volume":"72","author":"Van Praet L","year":"2013","unstructured":"Van Praet L, Van den Bosch FE, Jacques P, et al. (2013): Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model. Ann Rheum Dis 72: 414-417.","journal-title":"Ann Rheum Dis"},{"key":"ref-1547451","doi-asserted-by":"publisher","DOI":"10.1002\/ar.30558"},{"key":"ref-1547452","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12967-016-0989-3","article-title":"Microbiota and chronic inflammatory arthritis: an interwoven link","volume":"14","author":"Diamanti AP","year":"2016","unstructured":"Diamanti AP, Rosado MM, Lagan\u00e1 B, D\u2019Amelio R (2016): Microbiota and chronic inflammatory arthritis: an interwoven link. J Transl Med 14: 233.","journal-title":"J Transl Med"},{"key":"ref-1547453","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jbspin.2016.02.017","article-title":"The gut in spondyloarthritis","volume":"83","author":"Wendling D","year":"2016","unstructured":"Wendling D (2016): The gut in spondyloarthritis. Joint Bone Spine 83: 401-405.","journal-title":"Joint Bone Spine"},{"key":"ref-1547454","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3748\/wjg.15.2443","article-title":"Gastrointestinal lesions associated with spondyloarthropathies","volume":"15","author":"Orlando A","year":"2009","unstructured":"Orlando A, Renna S, Perricone G, Cottone M (2009): Gastrointestinal lesions associated with spondyloarthropathies. World J Gastroenterol 15: 2443-2448.","journal-title":"World J Gastroenterol"},{"key":"ref-1547455","doi-asserted-by":"crossref","first-page":"G171","DOI":"10.1152\/ajpgi.00048.2015","article-title":"Homeostasis of the gut barrier and potential biomarkers","volume":"312","author":"Wells JM","year":"2017","unstructured":"Wells JM, Brummer RJ, Derrien M, et al. (2017): Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastointest Liver Physiol 312: G171-G193.","journal-title":"Am J Physiol Gastointest Liver Physiol"},{"key":"ref-1547456","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4240\/wjgs.v2.i3.61","article-title":"Non-invasive assessment of barrier integrity and function of the human gut","volume":"2","author":"Grootjans J","year":"2010","unstructured":"Grootjans J, Thuijls G, Verdam F, et al. (2010): Non-invasive assessment of barrier integrity and function of the human gut. World J Gastointest Surg 2: 61-69.","journal-title":"World J Gastointest Surg"},{"key":"ref-1547457","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society for classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit M","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 E, et al. (2011): The Assessment of SpondyloArthritis International Society for classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70: 25-31.","journal-title":"Ann Rheum Dis"},{"key":"ref-1547458","doi-asserted-by":"crossref","first-page":"e000284","DOI":"10.1136\/rmdopen-2016-000284","article-title":"Update in interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice","volume":"3","author":"Miossec P","year":"2017","unstructured":"Miossec P (2017): Update in interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice. RMD Open 3, e000284.","journal-title":"RMD Open"},{"key":"ref-1547459","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia F","year":"2009","unstructured":"Ciccia F, Bombardieri M, Principato A, et al. (2009): Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 60: 955-965.","journal-title":"Arthritis Rheum"},{"key":"ref-1547460","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patients with ankylosing spondylitis","volume":"30","author":"Mei Y","year":"2011","unstructured":"Mei Y, Pan F, Gao J, et al. (2011): Increased serum IL-17 and IL-23 in the patients with ankylosing spondylitis. Clin Rheumatol 30: 269-273.","journal-title":"Clin Rheumatol"},{"key":"ref-1547461","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th-17-mediated adaptive immune response","volume":"13","author":"Appel H","year":"2011","unstructured":"Appel H, Maier R, Wu P, et al. (2011): Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th-17-mediated adaptive immune response. Arthritis Res Ther 13: R95.","journal-title":"Arthritis Res Ther"},{"key":"ref-1547462","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcma.2012.05.006","article-title":"Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis","volume":"75","author":"Chen WS","year":"2012","unstructured":"Chen WS, Chang YS, Lin KC, et al. (2012): Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J Chin Med Assoc 75: 303-308.","journal-title":"J Chin Med Assoc"},{"key":"ref-1547463","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7754\/Clin.Lab.2015.150801","article-title":"Elevated serum levels of sclerostin are associated with high disease activity and functional impairment in patients with axial spondyloarthritis","volume":"62","author":"Muntean L","year":"2016","unstructured":"Muntean L, Lungu A, Gheorghe SR, et al. (2016): Elevated serum levels of sclerostin are associated with high disease activity and functional impairment in patients with axial spondyloarthritis. Clin Lab 62: 589-597.","journal-title":"Clin Lab"},{"key":"ref-1547464","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mi.2016.14","article-title":"Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications","volume":"9","author":"Boyapati RK","year":"2016","unstructured":"Boyapati RK, Rossi AG, Satsangi J, Ho GT (2016): Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol 9: 567-582.","journal-title":"Mucosal Immunol"},{"key":"ref-1547465","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1535370216681551","article-title":"Calprotectin in rheumatic diseases","volume":"242","author":"Ometto F","year":"2017","unstructured":"Ometto F, Friso L, Astorri D, et al. (2017): Calprotectin in rheumatic diseases. Exp Biol Med (Maywood) 242: 859-873.","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref-1547466","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13075-014-0413-4","article-title":"Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis","volume":"2014, 16","author":"Turina MC","year":"2014","unstructured":"Turina MC, Yeremenko N, Paramarta JE, et al. (2014): Calprotectin (S100A8\/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis. Arthritis Res Ther 2014, 16: 413.","journal-title":"Arthritis Res Ther"},{"key":"ref-1547467","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gut.47.4.506","article-title":"A simple method for assessing intestinal inflammation in Crohn\u2019s disease","volume":"47","author":"Tibble J","year":"2000","unstructured":"Tibble J, Teahon K, Thjodleifsson B, et al. (2000): A simple method for assessing intestinal inflammation in Crohn\u2019s disease. Gut 47: 506-513.","journal-title":"Gut"},{"key":"ref-1547468","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.autrev.2016.02.002","article-title":"An update on biomarkers in axial spondyloarthritis","volume":"15","author":"Prajzlerov\u00e1 K","year":"2016","unstructured":"Prajzlerov\u00e1 K, Grobeln\u00e1 K, Pavelka K, et al. (2016): An update on biomarkers in axial spondyloarthritis. Autoimmunity Rev 15: 501-509.","journal-title":"Autoimmunity Rev"},{"key":"ref-1547469","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2015-208025","article-title":"Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis","volume":"75","author":"Cypers H","year":"2016","unstructured":"Cypers H, Varkas G, Beeckman S, et al. (2016): Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Ann Rheum Dis 75: 1357-1362.","journal-title":"Ann Rheum Dis"},{"key":"ref-1547470","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klinberg E","year":"2017","unstructured":"Klinberg E, Strid H, St\u00e5hl A, et al. (2017): A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis. Arth Res Ther 19: 21.","journal-title":"Arth Res Ther"},{"key":"ref-1547471","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2017.1299216"},{"key":"ref-1547472","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.semarthrit.2016.08.014","article-title":"The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthritis and scleroderma?","volume":"46","author":"Klavdianou K","year":"2017","unstructured":"Klavdianou K, Liossis SN, Sakkas L, Daoussis D (2017): The role of Dickkopf-1 in joint remodeling and fibrosis: A link connecting spondyloarthritis and scleroderma? Semin Arthritis Rheum 46: 430-438.","journal-title":"Semin Arthritis Rheum"},{"key":"ref-1547473","doi-asserted-by":"crossref","first-page":"e0134974","DOI":"10.1371\/journal.pone.0134974","article-title":"Increase in Dickkopf-1 serum level in recent spondyloarthritis. Data from the DESIR cohort","volume":"10","author":"Nocturne G","year":"2015","unstructured":"Nocturne G, Pavy S, Boudaoud S, et al. (2015): Increase in Dickkopf-1 serum level in recent spondyloarthritis. Data from the DESIR cohort. PLoS One 10: e0134974.","journal-title":"PLoS One"},{"key":"ref-1547474","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","article-title":"Evidence that Dkk-1 is dysfunctional in ankylosisg spondylitis","volume":"62","author":"Daoussis D","year":"2010","unstructured":"Daoussis D, Liossis SN, Solomou EE, et al. (2010): Evidence that Dkk-1 is dysfunctional in ankylosisg spondylitis. Arthritis Rheum 62: 150-158.","journal-title":"Arthritis Rheum"},{"key":"ref-1547475","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/annrheumdis-2013-203854","article-title":"Degree of bone marrow oedema in sacroiliac joint of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from GIANT cohort","volume":"73","author":"Van Praet L","year":"2014","unstructured":"Van Praet L, Jans L, Carron P, et al. (2014): Degree of bone marrow oedema in sacroiliac joint of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from GIANT cohort. Ann Rheum Dis 73: 1186-1189.","journal-title":"Ann Rheum Dis"},{"key":"ref-1547476","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jbspin.2016.05.008","article-title":"Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters","volume":"84","author":"Sakellariou GT","year":"2017","unstructured":"Sakellariou GT, Iliopoulos A, Konsta M, et al. (2017): Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters. Join Bone Spine 84: 309-315.","journal-title":"Join Bone Spine"},{"key":"ref-1547477","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","article-title":"IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis","volume":"18","author":"Shaw AT","year":"2016","unstructured":"Shaw AT, Maeda Y, Gravallese EM (2016): IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis. Arthritis Res Ther 18: 104.","journal-title":"Arthritis Res Ther"},{"key":"ref-1547478","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00109-017-1557-x","article-title":"Layered defense: how mucus and tight junctions seal the intestinal barrier","volume":"95","author":"Capaldo CT","year":"2017","unstructured":"Capaldo CT, Powell DN, Kalman D (2017): Layered defense: how mucus and tight junctions seal the intestinal barrier. J Mol Med 95: 927-934.","journal-title":"J Mol Med"},{"key":"ref-1547479","first-page":"66","article-title":"Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation","author":"Garcia-Hernandez V","year":"1397","unstructured":"Garcia-Hernandez V, Quiros M, Nusrat A (2017) : Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Ann NY Acad Sci 1397: 66-79.","journal-title":"Ann NY Acad Sci"},{"key":"ref-1547480","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00424-016-1914-6","article-title":"Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases","volume":"469","author":"Barmeyer C","year":"2017","unstructured":"Barmeyer C, Fromm M, Schultzke JD (2017): Active and passive involvement of claudins in the pathophysiology of intestinal inflammatory diseases. Pflugers Arch\u2013Eur J Physiol 469: 15-26.","journal-title":"Pflugers Arch\u2013Eur J Physiol"},{"key":"ref-1547481","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00428-014-1651-1","article-title":"Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn\u2019s disease?","volume":"465","author":"Goswami P","year":"2014","unstructured":"Goswami P, Das P, Verma AK, et al. (2014): Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn\u2019s disease? Virchows Archiv 465: 521-530.","journal-title":"Virchows Archiv"},{"key":"ref-1547482","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/MCG.0b013e31819f5652","article-title":") Urine-based detection of intestinal tight junction loss","volume":"44","author":"Thuijls G","year":"2010","unstructured":"Thuijls G, Derikx JP, de Haan JJ, et al. (2010: ) Urine-based detection of intestinal tight junction loss. J Clin Gastroenterol 44: e14-e19.","journal-title":"J Clin Gastroenterol"},{"key":"ref-1547483","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3892\/mco.2015.626","article-title":"Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer","volume":"3","author":"Karabulut M","year":"2015","unstructured":"Karabulut M, Alis H, Bas K, et al. (2015): Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. Mol Clin Oncol 3: 1255-1267.","journal-title":"Mol Clin Oncol"},{"key":"ref-1547484","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/CMR.0000000000000241","article-title":"Clinical significance of serum claudin-1 levels in melanoma patients","volume":"26","author":"Tas F","year":"2016","unstructured":"Tas F, Bilgin E, Erturk K, Duranyildiz D (2016): Clinical significance of serum claudin-1 levels in melanoma patients. Melanoma Res 26: 377-381.","journal-title":"Melanoma Res"},{"key":"ref-1547485","first-page":"930","article-title":"Serum levels of endocan, claudin-5 and cytokines in migraine","volume":"20","author":"Y\u00fccel M","year":"2016","unstructured":"Y\u00fccel M, Kotan D, Gurol \u00c7ift\u00e7i G, et al. (2016): Serum levels of endocan, claudin-5 and cytokines in migraine. Eur Rev Med Pharmacol Sci 20: 930-936.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref-1547486","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1074\/mcp.M117.068577","article-title":"Database-augmented mass spectrometry analysis of exosomes identifies claudin 3 as a putative prostate cancer biomarker","volume":"16","author":"Worst TS","year":"2017","unstructured":"Worst TS, von Hardenberg J, Gross JC, et al. (2017): Database-augmented mass spectrometry analysis of exosomes identifies claudin 3 as a putative prostate cancer biomarker. Mol Cell Proteomics 16: 998-1008.","journal-title":"Mol Cell Proteomics"},{"key":"ref-1547487","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia F","year":"2017","unstructured":"Ciccia F, Guggino G, Rizzo A, et al. (2017): Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann Rheum Dis 76: 1123-1132.","journal-title":"Ann Rheum Dis"},{"key":"ref-1547488","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2014.10.001","article-title":"Enterocyte fatty acid binding proteins (FABPs): different functions of liver-and intestinal-FABPs in the intestine","volume":"93","author":"Gajda AM","year":"2015","unstructured":"Gajda AM, Storch J (2015): Enterocyte fatty acid binding proteins (FABPs): different functions of liver-and intestinal-FABPs in the intestine. Prostaglandins Leukot Essent Fatty Acids 93: 9-16.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref-1547489","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0039-6060(97)90363-9","article-title":"Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia","volume":"121","author":"Lieberman JM","year":"1997","unstructured":"Lieberman JM, Sacchettini J, Marks C, Marks WH (1997): Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 121: 335-342.","journal-title":"Surgery"},{"key":"ref-1547490","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MCG.0b013e31819194b0","article-title":"A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP","volume":"43","author":"Derikx JP","year":"2009","unstructured":"Derikx JP, Vreugdenhil AC, Van den Neucker AM, et al. (2009): A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 43: 727-733.","journal-title":"J Clin Gastroenterol"},{"key":"ref-1547491","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.regpep.2007.12.002","article-title":"Intestinal fatty binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis","volume":"147","author":"Wiercinska-Drapalo A","year":"2007","unstructured":"Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, et al. (2007): Intestinal fatty binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept 147: 25-28.","journal-title":"Regul Pept"},{"key":"ref-1547492","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jpedsurg.2009.09.024","article-title":"Urinary intestinal fatty acid-binding protein concentration predict extend of disease in necrotizing enterocolitis","volume":"45","author":"Evennett NJ","year":"2010","unstructured":"Evennett NJ, Hall NJ, Pierro A, Eaton S (2010): Urinary intestinal fatty acid-binding protein concentration predict extend of disease in necrotizing enterocolitis. J Pediatr Surg 45: 735-740.","journal-title":"J Pediatr Surg"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-85045-129820","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-85045-129820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:36:06Z","timestamp":1767947766000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Spondyloarthritis-patients-with-and-without-intestinal-symptoms-searching-for-discriminating,85045,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,20]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["85045"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2019.92802","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,20]]}}}